![(E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione structure](/static/products/372/372979-18-5.png)
(E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione
TL;DR: (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione (CAS 372979-18-5) is a chemical compound with molecular formula C26H18N4O2 and molecular weight 418.14 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
3-[(E)-anthracen-9-ylmethylideneamino]-8-methyl-1,5-dihydropyrimido[5,4-b]indole-2,4-dione
Also Known As: (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione, 3-[(E)-anthracen-9-ylmethylideneamino]-8-methyl-1,5-dihydropyrimido[5,4-b]indole-2,4-dione, 3-{[(E)-anthracen-9-ylmethylidene]amino}-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione
| Molecular Formula | C26H18N4O2 |
|---|---|
| Molecular Weight | 418.14 g/mol |
| LogP | 4.66812 |
| Topological Polar Surface Area | 83.01 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 3 |
| Rotatable Bonds | 2 |
| Exact Mass | 418.14297 |
| Heavy Atoms | 32 |
| Complexity | 1782.9529 |
Chemical Identifiers
| CAS Number | 372979-18-5 |
|---|---|
| SMILES | CC1=CC2=C(C=C1)NC3=C2NC(=O)N(C3=O)/N=C/C4=C5C=CC=CC5=CC6=CC=CC=C64 |
Product Overview
(E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione (CAS 372979-18-5), with molecular formula C26H18N4O2 and molecular weight 418.14 g/mol. IUPAC: 3-[(E)-anthracen-9-ylmethylideneamino]-8-methyl-1,5-dihydropyrimido[5,4-b]indole-2,4-dione.
Chemical Property Profile of (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione
Property Insights of (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione
The XLogP value of 4.66812 indicates that (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 83.01 Ų falls within the moderate polarity range, balancing permeability and solubility for (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione. Following Lipinski's Rule of Five, (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione has 2 hydrogen bond donor(s) and 3 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione?
The CAS number of (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione is 372979-18-5.
What is the molecular formula of (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione?
The molecular formula of (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione is C26H18N4O2.
What is the molecular weight of (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione?
The molecular weight of (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione is 418.14 g/mol.
Where can I buy (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione?
You can request a quote for (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione?
Yes, KEHONG BIO provides custom synthesis services for (E)-3-((anthracen-9-ylmethylene)amino)-8-methyl-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.